After record-breaking demand for injectables, BD to expand in Spain with $200M Zaragoza plant
Following the increase in vaccinations doled out in the last year, New Jersey-based BD is doubling down on demand for injectables and putting its faith in its Spanish operations.
BD will begin construction of a $200 million manufacturing facility in Zaragoza that will produce drug delivery devices for vaccines and biologics, the company announced this week. That plant will be the company’s fourth in the country and represent part of the $1.2 billion supply chain investment the company has pledged to make over the next four years.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.